UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.429-438

2011

Volltextzugriff (PDF)

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

British journal of cancer, 2000-01, Vol.82 (1), p.93-97

2000

Volltextzugriff (PDF)

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

The lancet oncology, 2008-04, Vol.9 (4), p.331-341

2008

Volltextzugriff (PDF)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Volltextzugriff (PDF)

Improvement in quality of life for cancer patients treated with epoetin alfa

European journal of cancer care, 2001-09, Vol.10 (3), p.183-191

2001

Volltextzugriff (PDF)

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

The Lancet (British edition), 2008-03, Vol.371 (9618), p.1098-1107

2008

Volltextzugriff (PDF)

Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey

Oncology, 2006-01, Vol.70 (1), p.34-48

2006

Volltextzugriff (PDF)

Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study Group

Annals of oncology, 1999-02, Vol.10 (2), p.205

1999

Volltextzugriff (PDF)

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Volltextzugriff (PDF)

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

British journal of cancer, 2013-03, Vol.108 (5), p.1195-1208

2013

Volltextzugriff (PDF)

Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial

Annals of oncology, 2015-07, Vol.26 (7), p.1340-1346

2015

Volltextzugriff (PDF)

Routine blood group and antibody screening prior to emergency laparoscopy

Annals of the Royal College of Surgeons of England, 2018-04, Vol.100 (4), p.322-325

2018

Volltextzugriff (PDF)

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2293-2306

2004

Volltextzugriff (PDF)

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

British journal of cancer, 2005-05, Vol.92 (10), p.1869-1876

2005

Volltextzugriff (PDF)

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

European journal of cancer (1990), 2011-11, Vol.47 (17), p.2517-2530

2011

Volltextzugriff (PDF)

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer

Breast cancer research and treatment, 2014-04, Vol.144 (2), p.331-341

2014

Volltextzugriff (PDF)

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy

Radiotherapy and oncology, 2012-08, Vol.104 (2), p.143-147

2012

Volltextzugriff (PDF)

Management of Cancer‐Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the European Cancer Anemia Survey

The oncologist (Dayton, Ohio), 2005-10, Vol.10 (9), p.743-757

2005

Volltextzugriff (PDF)

A prognostic tool to predict fatigue in women with early-stage breast cancer undergoing radiotherapy

Breast (Edinburgh), 2013-08, Vol.22 (4), p.504-509

2013

Volltextzugriff (PDF)

How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients

British journal of cancer, 2008-01, Vol.98 (1), p.34-38

2008

Volltextzugriff (PDF)

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial

British journal of radiology, 2012-09, Vol.85 (1017), p.e647-e653

2012

Volltextzugriff (PDF)

Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom

Clinical therapeutics, 2005-08, Vol.27 (8), p.1295-1310

2005

Volltextzugriff (PDF)

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

Nature genetics, 1992-10, Vol.2 (2), p.132-134

1992

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Improvement in quality of life for cancer patients treated with epoetin alfa

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey

Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study Group

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial

Routine blood group and antibody screening prior to emergency laparoscopy

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy

Management of Cancer‐Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the European Cancer Anemia Survey

A prognostic tool to predict fatigue in women with early-stage breast cancer undergoing radiotherapy

How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial

Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

Aktive Filter

Suchergebnisse filtern